(19)
(11) EP 1 267 925 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
29.08.2007 Bulletin 2007/35

(45) Mention of the grant of the patent:
13.06.2007 Bulletin 2007/24

(21) Application number: 01911971.8

(22) Date of filing: 20.03.2001
(51) International Patent Classification (IPC): 
A61K 39/395(2006.01)
A61K 31/70(2006.01)
C07K 16/14(2006.01)
G01N 33/569(2006.01)
 A61K 38/12(2006.01)
A61P 31/10(2006.01)
A61K 47/38(2006.01)
(86) International application number:
PCT/GB2001/001195
(87) International publication number:
WO 2001/076627 (18.10.2001 Gazette 2001/42)

(54)

TREATMENT OF FUNGAL INFECTION WITH POLYENE OR BETA GLUCAN SYNTHASE INHIBITOR ANTIFUNGALS COMBINED WITH ANTI HSP90 ANTIBODIES

BEHANDLUNG VON PILZINFEKTION MIT POLYENEN ODER BETA GLUCAN SYNTHESE HEMMERN KOMBINIERT MIT ANTI-HSP ANTIKÖRPERN

TRAITEMENT DES INFECTIONS FONGIQUES AVEC DES ANTIFONGIQUES A BASE D'INHIBITEUR DE SYNTHASE POLYENE OU BETA GLUCANE COMBINES A DES ANTICORPS ANTI-HSP90

(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

(30) Priority: 06.04.2000 GB 0008305

(43) Date of publication of application:
02.01.2003 Bulletin 2003/01

(60) Divisional application:
07075188.8 / 1818062
07075462.7

(73) Proprietor: Neutec Pharma Limited
Camberley, Surrey GU16 7SR (GB)

(72) Inventor:
  • BURNIE, James Peter
    Alderley Edge, Cheshire SK9 7PY (GB)

(74) Representative: Arends, William Gerrit et al
Lloyd Wise Commonwealth House 1-19 New Oxford Street
London WC1A 1LW
London WC1A 1LW (GB)


(56) References cited: : 
EP-A- 0 861 892
 WO-A-94/04676
   
  • R. MATTHEWS AND J. BURNIE: "The role of hsp 90 in fungal infection" IMMUNOLOGY TODAY, vol. 13, no. 9, 1992, pages 345-348, XP001008081
  • MATTHEWS R C ET AL: "AUTOANTIBODY TO HEAT-SHOCK PROTEIN 90 CAN MEDIATE PROTECTION AGAINST SYSTEMIC CANDIDOSIS" IMMUNOLOGY,GB,OXFORD, vol. 74, no. 1, 1 September 1991 (1991-09-01), pages 20-24, XP002067298 ISSN: 0019-2805
   
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).